Last Price$19.24NASDAQ Closing Price as of 4:00PM ET 7/23/19

Today's Change+0.33(1.75%)
Bid (Size)$19.20 (8)
Ask (Size)$19.24 (5)
Day Low / High$18.89 - 19.36
Volume87.5 K

View Biotechnology IndustryPeer Comparison as of 07/23/2019


Alector Inc ( NASDAQ )

Price: $19.24
Change: +0.33 (1.75%)
Volume: 87.5 K
4:00PM ET 7/23/2019

OPKO Health Inc ( NASDAQ )

Price: $2.08
Change: +0.01 (0.48%)
Volume: 2.3 M
4:00PM ET 7/23/2019

Eidos Therapeutics Inc ( NASDAQ )

Price: $36.55
Change: +0.02 (0.05%)
Volume: 146.7 K
4:00PM ET 7/23/2019

Sangamo Therapeutics Inc ( NASDAQ )

Price: $11.89
Change: +0.05 (0.42%)
Volume: 884.3 K
4:00PM ET 7/23/2019

Editas Medicine Inc ( NASDAQ )

Price: $25.39
Change: +0.60 (2.42%)
Volume: 612.0 K
4:00PM ET 7/23/2019

Read more news Recent News

Sector Update: Moderate Gains for Health Care Stocks Near Thursday Close
3:51PM ET 7/18/2019 MT Newswires

Top Health Care Stocks JNJ +0.05% PFE +0.66% ABT +2.01% MRK +0.96% AMGN +1.44% Health care stocks continue to rise in late trade, with the NYSE Health...

Sector Update: Slim Advance for Health Care Stocks
2:06PM ET 7/18/2019 MT Newswires

Top Health Care Stocks JNJ -0.20% PFE +0.26% ABT +1.53% MRK +0.53% AMGN +1.07% Health care stocks were rising in recent trade, with the NYSE...

Sector Update: Health Care
1:35PM ET 7/18/2019 MT Newswires

Health care stocks were rising in recent trade, with the NYSE Health Care Index climbing nearly 0.3% while shares of health care companies in the S&P 500...

MT Newswires After-Hours News Movers
5:44PM ET 7/17/2019 MT Newswires

Some of the stocks moving on news-driven events in Wednesday's after-hours include: EBAY, +6.58% ALEC, +4.22% IBM, +0.93% TCBI, +0.24% CCI, -0.17% KEY,...

View all Commentary and Analysis

Prevail Therapeutics Proposes IPO Terms
11:46AM ET 6/13/2019 Seeking Alpha

Alector: Targeted Therapies For Neurodegenerative Diseases
12:38PM ET 5/20/2019 Seeking Alpha

Cortexyme IPO Isn't Cheap
5:59PM ET 5/06/2019 Seeking Alpha

Big Pharma, Green Trucks And Jobs Report (Stocks To Watch Podcast)
7:30AM ET 3/03/2019 Seeking Alpha

Company Profile

Business DescriptionAlector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA. View company web site for more details
Address151 Oyster Point Boulevard
South San Francisco, California 94080
Number of EmployeesN/A
Recent SEC Filing06/13/20198-K
President, Chief Executive Officer & DirectorArnon Rosenthal
Chief Financial & Accounting OfficerCalvin Yu
Chief Medical OfficerRobert Paul
Chief Development OfficerRobert S. King

Company Highlights

Price Open$19.00
Previous Close$18.91
52 Week Range$15.16 - 27.00
Market Capitalization$1.3 B
Shares Outstanding68.9 M
SectorHealth Technology
Next Earnings Announcement08/12/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.81
Beta vs. S&P 500N/A
Revenue$27.7 M
Net Profit Margin-256.67%
Return on Equity-45.17%

Analyst Ratings as of 07/12/2019

Consensus RecommendationConsensus Icon
Powered by Factset